Evogene Company Description

Evogene Ltd., together with its subsidiaries, operates as a computational biology company in Israel, the United States, Israel, Brazil, and internationally.

The company focuses on product discovery and development in life-science based industries, including human health, agriculture, and other industrial applications through its computational predictive biology (CPB) platform.

It operates through three segments: Agriculture, Human Health, and other Industrial Applications. The Agriculture segment develops seed traits, ag-chemical products, and ag-biological products to enhance plant performance.

The Human Health segment discovers and develops human microbiome-based therapeutics for the treatment of immuno-oncology, gastrointestinal inflammatory related disorders, and antimicrobial resistance organisms.

The Industrial Applications segment focuses on the development and commercialization of improved castor bean seeds for industrial uses.

The company also provides medical cannabis products. Evogene Ltd. was incorporated in 1999 and is headquartered in Rehovot, Israel.

Evogene Ltd.

Country	Israel
Founded	1999
Industry	Biotechnology
Sector	Healthcare
Employees	117
CEO	Ofer Haviv

Contact Details

Address: 13 Gad Feinstein Street Rehovot, 7638517 Israel
Phone	972 8 931 1900
Website	evogene.com

Stock Details

Ticker Symbol	EVGN
Exchange	Tel Aviv Stock Exchange
Fiscal Year	January - December
Reporting Currency	USD
ISIN Number	IL0011050551
SIC Code	2836

Key Executives

Name	Position
Amit Noam Capt. res.	Chief Executive Officer of Lavie Bio Ltd.
Dr. Dan Jacob Gelvan Ph.D.	Chief Executive Officer of Ag Plenus Ltd.
Yoash Zohar	Chief Executive Officer of Casterra Ag Ltd.
Dr. Elran Hillel Haber M.B.A., Ph.D.	Chief Executive Officer of Biomica Ltd
Ofer Haviv CPA	Chief Executive Officer, President and Director
Yaron Eldad	Chief Financial Officer
Liat Foigel Wejgman	Vice President of Human Resources
Russ Putland	Executive Vice President Commercial and General Manager USA